Get the Stockscreener App
28.63
0.62%
-0.18
After Hours:
28.58
-0.05
-0.17%
Surmodics Inc stock is traded at $28.63, with a volume of 159.59K.
It is down -0.62% in the last 24 hours and down -10.87% over the past month.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.
See More
Previous Close:
$28.81
Open:
$28.81
24h Volume:
159.59K
Relative Volume:
0.77
Market Cap:
$409.34M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
75.34
EPS:
0.38
Net Cash Flow:
$9.86M
1W Performance:
-1.68%
1M Performance:
-10.87%
6M Performance:
+5.10%
1Y Performance:
-25.94%
1-Day Range:
$28.49
$28.81
1-Week Range:
$28.49
$29.16
52-Week Range:
$26.00
$40.38
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
28.63 | 411.91M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Upgrade | Lake Street | Hold → Buy |
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
How institutional ownership impacts Surmodics Inc. stockQuarterly Market Summary & Risk Controlled Stock Pick Alerts - newser.com
Applying big data sentiment scoring on Surmodics Inc.2025 Price Targets & Verified Chart Pattern Trade Signals - newser.com
How moving averages guide Surmodics Inc. trading2025 Price Action Summary & Weekly Consistent Profit Watchlists - newser.com
What MACD signals say about Surmodics Inc.July 2025 Review & Weekly High Potential Alerts - newser.com
Has Surmodics Inc. formed a bullish divergence2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com
Surmodics (NASDAQ:SRDX) Receives "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Measuring Surmodics Inc.’s beta against major indicesBull Run & Reliable Volume Spike Trade Alerts - newser.com
Is Surmodics Inc. stock supported by strong cash flowsQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Surmodics Inc Stock Analysis and ForecastGrowth vs. Value Investing & High Yield Trading Alerts - earlytimes.in
Statistical indicators supporting Surmodics Inc.’s strengthWeekly Volume Report & Fast Gain Swing Alerts - newser.com
Does Surmodics Inc. fit your quant trading model2025 Trading Volume Trends & Accurate Trade Setup Notifications - newser.com
Risk vs reward if holding onto Surmodics Inc.July 2025 Levels & Verified Chart Pattern Signals - newser.com
Multi factor analysis applied to Surmodics Inc.Quarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Surmodics, Inc. (NASDAQ:SRDX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Short interest data insights for Surmodics Inc.Entry Point & Short-Term Trading Opportunity Alerts - newser.com
Is Surmodics Inc. stock a buy for dividend growthAnalyst Upgrade & Free Real-Time Market Sentiment Alerts - newser.com
How to monitor Surmodics Inc. with trend dashboards2025 Short Interest & Reliable Price Action Trade Plans - newser.com
Published on: 2025-10-02 22:35:48 - newser.com
Is Surmodics Inc. forming a reversal patternTrade Performance Summary & Verified Momentum Stock Alerts - newser.com
US FTC delays GTCR-Surmodics evidentiary hearing until Feb. 2, 2026 - MLex
What drives Surmodics Inc stock priceQuarterly Earnings Review & Low Risk Capital Growth Plans - earlytimes.in
Is Surmodics Inc a good long term investmentTrend Following Strategies & Outstanding Return Stocks - earlytimes.in
Published on: 2025-09-28 02:08:28 - newser.com
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Surmodics Inc Stock (SRDX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DANTZKER DAVID | Director |
Feb 13 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
44,399 |
| BEDOYA JOSE H | Director |
Feb 14 '25 |
Option Exercise |
27.30 |
5,275 |
144,008 |
34,232 |
| KNIGHT SUSAN E | Director |
Jan 24 '25 |
Option Exercise |
27.30 |
7,358 |
200,873 |
42,506 |
| Arens Timothy J. | Chief Financial Officer |
Nov 26 '24 |
Sale |
39.44 |
7,009 |
276,453 |
70,350 |
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):